Journal of Critical CareVolume 66, December 2021, Pages 123-125Influence of IL-6 levels on patient survival in COVID-19Author links open overlay panelNishkantha Arulkumaran PhD a 1, Timothy A.C. Snow FFICM a 1, Adarsh Kulkarni MD a, David Brealey PhD a, Hannah M. Rickman PhD b c d, Chloe Rees-Spear BSc e f g, Moira J. Spyer BSc f, Judith Heaney BSc b f, Edmund Garr PhD h k, Bryan Williams FRCP m, Peter Cherepanov PhD i, George Kassiotis PhD j, Michael P. Lunn PhD e h, Gareth Ambler PhD l, Catherine Houlihan PhD b e f, Laura E. McCoy PhD b d, Eleni Nastouli FRCPath b d f, Mervyn Singer FRCP aShow moreShareCitehttps://doi.org/10.1016/j.jcrc.2021.08.013Get rights and contentPrevious article in issueNext article in issueKeywordsCOVID-19Interleukin-6AntibodiesMortalityRecommended articlesCited by (0)1Authors contributed equally.View Abstract© 2021 Elsevier Inc. All rights reserved.